dipyridamole has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effect is increased significantly, especially in the sensory sphere (tactile, temperature and pain sensitivity), when the drug is used in combination with curantyl in dosage 50 mg twice daily for 3 months." | 1.35 | [The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy]. ( Al-Zamil, MKh, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Zamil, MKh | 1 |
| Taskiran, M | 1 |
| Fritz-Hansen, T | 1 |
| Rasmussen, V | 1 |
| Larsson, HB | 1 |
| Hilsted, J | 1 |
2 other studies available for dipyridamole and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
[The use of dipyridamole (curantyl) in combination with alpha-lipoic acid in the treatment of diabetic neuropathy with retinopathy].
Topics: Adult; Aged; Antioxidants; Diabetic Neuropathies; Diabetic Retinopathy; Dipyridamole; Drug Therapy, | 2008 |
Decreased myocardial perfusion reserve in diabetic autonomic neuropathy.
Topics: Adult; Age of Onset; Albuminuria; Blood Pressure; Diabetic Neuropathies; Diabetic Retinopathy; Dipyr | 2002 |